Are you Dr. Iglehart?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Brigham And Womens Hospital
Boston, MA 02115Phone+1 617-732-6437- Is this information wrong?
Summary
- Dr. James Iglehart, MD is a general surgeon in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and Salem Hospital.
Education & Training
- Duke University HospitalFellowship, Thoracic Surgery, 1977 - 1984
- Duke University HospitalResidency, Surgery, 1975 - 1977
- Harvard Medical SchoolClass of 1975
Certifications & Licensure
- MA State Medical License 1999 - 2018
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsOverexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple negative breast and serous ovarian cancersNicolai Juul Birkbak, Yi Li, Shailja Pathania, April Greene-Colozzi, Matija Dreze, Christian Bowman-Colin, Zsofia Sztupinszki, Marcin Krzystanek, Miklos Diossy, Nadine...> ;Annals of Oncology. 2018 Apr 1
- 83 citationsCombination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases.Jing Ni, Shakti Ramkissoon, Shaozhen Xie, Shom Goel, Daniel G. Stover, H Guo, Victor Luu, Eugenio Marco, Lori A. Ramkissoon, Yun Jee Kang, Marika Hayashi, Quang-Dé Ngu...> ;Nature Medicine. 2016 Jul 1
- 2 citationsIdentification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA.Bose Kochupurakkal, J. Dirk Iglehart> ;Genomics Data. 2016 Mar 1
- Join now to see all
Grant Support
- Communications, Planning And Administration CoreNational Cancer Institute2008–2009
- Avon SupplementNational Cancer Institute2008–2009
- Developmental Research ProgramNational Cancer Institute2005–2009
- Career Development ProgramNational Cancer Institute2005–2009
- Dana-Farber/Harvard Spore In Breast CancerNational Cancer Institute2000–2009
- Avon-Nci PFP PROGRAM: Predicting Treatment Response In ER Positive Breat CancerNational Cancer Institute2008
- Avon NCI Progress For Patients SupplementNational Cancer Institute2008
- Advanced Training In Surgical OncologyNational Cancer Institute2001–2008
- C-6: Communications, Planning, And AdministrationNational Cancer Institute2005–2007
- Developmental ProjectsNational Cancer Institute2000–2002
- Career Development AwardsNational Cancer Institute2000–2002
- Developmental Research ProgramNational Cancer Institute1997–2002
- Core--Breast Cancer Tissue And Animal Testing ResourceNational Cancer Institute1997–2002
- Career Development ProgramNational Cancer Institute1997–2002
- Spore In Breast CancerNational Cancer Institute1995–1998
- Planning A Program Of Research In Early Breast CancerNational Cancer Institute1994–1997
- Planning A Program Of Research In Early Breast CancerNational Cancer Institute1994
- P53 In Breast CancerNational Cancer Institute1994
- P53 In Human Breast CancerNational Cancer Institute1992–1993
- Expression Of Oncogenes In Human TumorsNational Cancer Institute1991
- Expression Of Oncongenes In Human TumorsNational Cancer Institute1988
- Expression Of RAS Oncogenes In Human TumorsNational Cancer Institute1986–1987
- Immunotherapy Of Murine Solid TumorsNational Cancer Institute1985
Professional Memberships
- Member
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Salem HospitalSalem, Massachusetts